MedTrace Logo

The Effectiveness of Lymphatic Bypass Supermicrosurgery

NCT05682885 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2025-01-22

No results posted yet for this study

Summary

This study evaluate the effectiveness of lymphatic bypass supermicrosurgery (LBS) and axillary lymph node dissection (ALND) compare to ALND alone to prevent breast cancer treatment-related lymphedema (BCRL).

Conditions

  • Breast Cancer Related Lymphedema
  • Lymphedema Arm

Interventions

PROCEDURE

Lymphatic Bypass Supermicrosurgery

Axillary Lymph Node Dissection with Lymphatic Bypass Supermicrosurgery

Sponsors & Collaborators

  • Dharmais National Cancer Center Hospital

    lead OTHER_GOV

Principal Investigators

  • Bayu Brahma, MD · Dharmais Hospital National Cancer Center, Indonesia

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-06
Primary Completion
2027-10-31
Completion
2027-11-18

Countries

  • Indonesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05682885 on ClinicalTrials.gov